MediBeacon
Germany - Mannheim
BiotechnologyFocus: Proprietary fluorescent tracer agents and transdermal detection systems
MediBeacon is a life sciences company focused on Proprietary fluorescent tracer agents and transdermal detection systems.
NephrologyImmunology
Employees
201-500
Open Jobs
2
Pipeline & Clinical Trials
Brilliance device sensor
Acute Kidney InjuryClinical Trials (1)
NCT03810833Tolerability and Background Fluorescence of the MediBeacon Transdermal GFR Measurement System
N/ALumitrace
Glomerular Filtration RateClinical Trials (1)
NCT07349797MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure
N/ALumitrace
Glomerular Filtration RateClinical Trials (1)
NCT07335614Evaluation of Protein Loading on Measurement of Renal Reserve
N/AFluorescein sodium and Zeiss FF450 fundus camera
RetinopathyClinical Trials (1)
NCT04008121Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Phase 1Below target dose MP-3180
Glomerular Filtration RateClinical Trials (1)
NCT02098187Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers
Phase 1Lumitrace
Ureter InjuryClinical Trials (1)
NCT07080008Evaluation of Lumitrace for Visualizing Ureters During Abdominopelvic Surgeries
Phase 1Lactulose/Rhamnose solution
Crohn DiseaseClinical Trials (1)
NCT03962998Oral Administration of MB-102 Versus Dual Sugar Testing for Gut Permeability
Phase 1MP-3180
Glomerular Filtration RateClinical Trials (1)
NCT02098174Pharmacokinetics of MP-3180 in Healthy Volunteers
Phase 1MB-102-- single dose of 4 µmol/kg
Acute Kidney InjuryClinical Trials (1)
NCT02772276Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types
Phase 2MB-102 DMID
Kidney DiseasesClinical Trials (1)
NCT05943977A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants
Phase 3MB-102
Kidney DiseasesClinical Trials (1)
NCT05777174Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring
Phase 3MB-102
Chronic Kidney DiseaseClinical Trials (1)
NCT05425719Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects
Phase 3Open Jobs (2)
Interview Prep Quick Facts
Portfolio: 12 clinical trials
Publications: 19 in PubMed
Open Roles: 2 active jobs
Hiring Trend
Stable
2
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles